Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.67 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | TYMS | P04818 | 1/20 | 0.35 |
| ▸ | FDPS | P14324 | 2/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL28993323 | 0.96 | SLC34A1 (0.61) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL298141 | 0.95 | SLC34A1 (0.73) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL28993322 | 0.92 | SLC34A1 (0.57) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL28585359 | 0.91 | SLC34A1 (0.67) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL9008718 | 0.91 | SLC34A1 (0.67) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL8508247 | 0.91 | SLC34A1 (0.67) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL11867838 | 0.91 | SLC34A1 (0.67) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL29828900 | 0.91 | SLC34A1 (0.67) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL7163381 | 0.91 | SLC34A1 (0.67) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL3850640 | 0.91 | SLC34A1 (0.67) | SLC34A1LMNAKDM4ECYP2C19KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120164216-A1 | PHARMACEUTICAL COMPOSITION OF DULOXETINE OR PHARMACEUTICALLY | MATE SANJAY (IN) | 2012-06-28 | — | — | US | claimed |
| WO-2010150219-A1 | PHARMACEUTICAL COMPOSITION OF DULOXETINE OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | WOCKHARDT RESEARCH CENTRE (IN) | 2010-12-29 | — | — | WO | claimed |
| US-6699885-B2 | Treating gastrointestinal disorders by administering solid oral dosage form of proton pump inhibitor and buffer; buffer inhibits degradation of the proton pump inhibitor by gastric acid; bioavailability | THE CURATORS OF THE UNIVERSITY OF MISSOURI | 2004-03-02 | — | — | US | claimed |
| US-4223115-A | ADDITION POLYMERIZABLE SYSTEM CONTAINING REDOX COUPLE CATALYST AND PHOSPHORUS COMPOUND | LORD CORPORATION (US) | 1980-09-16 | — | — | US | claimed |
| US-12376612-B2 | Edible concentrate comprising microfibrillated cellulose | CONOPCO INC. (US) | 2025-08-05 | — | — | US | disclosed |
| US-12042302-B2 | Enhanced ingestible event indicators and methods for making and using the same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2024-07-23 | — | — | US | disclosed |
| EP-4164408-A1 | DYE FOR FOODS, NUTRITIONAL SUPPLEMENTS, AND COSMETIC OR PHARMACEUTICAL PRODUCTS | Döhler GmbH (DE) | 2023-04-19 | — | — | EP | disclosed |
| CN-115970062-A | Bone cement-based drug sustained-release carrier and preparation method thereof | 泽田(山东)药业有限公司 | 2023-04-18 | — | — | CN | disclosed |
| US-20210338166-A1 | ENHANCED INGESTIBLE EVENT INDICATORS AND METHODS FOR MAKING AND USING THE SAME | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2021-11-04 | — | — | US | disclosed |
| CN-112544609-A | Cervical cell sample preservation solution and application thereof | 广州市金圻睿生物科技有限责任公司 | 2021-03-26 | — | — | CN | disclosed |
| EP-3579706-B1 | EDIBLE CONCENTRATE COMPRISING MICROFIBRILLATED CELLULOSE | UNILEVER NV (NL) | 2020-05-13 | — | — | EP | disclosed |
| WO-2018145886-A1 | EDIBLE CONCENTRATE COMPRISING MICROFIBRILLATED CELLULOSE | UNILEVER N.V. (NL) | 2018-08-16 | — | — | WO | disclosed |
| US-20120164216-A1 | PHARMACEUTICAL COMPOSITION OF DULOXETINE OR PHARMACEUTICALLY | MATE SANJAY (IN) | 2012-06-28 | — | — | US | disclosed |
| WO-2011121496-A1 | COMPOSITION COMPRISING INSULIN AND HERBAL OIL FOR TRANSDERMAL OR TRANSMUCOSAL ADMINISTRATION | WOCKHARDT LIMITED (IN) | 2011-10-06 | — | — | WO | disclosed |
| WO-2010150219-A1 | PHARMACEUTICAL COMPOSITION OF DULOXETINE OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | WOCKHARDT RESEARCH CENTRE (IN) | 2010-12-29 | — | — | WO | disclosed |
| US-20090250142-A1 | Mg or Mg-Alloy Housing and Method for Producing the Same | FUJITSU LIMITED (JP) | 2009-10-08 | — | — | US | disclosed |
| US-20060054249-A1 | Mg or Mg-alloy housing and method for producing the same | FUJITSU LIMITED | 2006-03-16 | — | — | US | disclosed |
| EP-0024032-B1 | PHOSPHATE GLASS COMPOSITIONS, AND GLASS-CERAMIC MATERIALS, AND METHODS OF MAKING THE SAME | FUJI PHOTO FILM CO., LTD. (JP) | 1985-11-21 | — | — | EP | disclosed |
| US-4366253-A | Phosphate glass compositions, and glass-ceramic materials, and methods of making the same | FUJI PHOTO FILM CO., LTD. (JP) | 1982-12-28 | — | — | US | disclosed |
| EP-0024032-A1 | Phosphate glass compositions, and glass-ceramic materials, and methods of making the same | FUJI PHOTO FILM CO., LTD. (JP) | 1981-02-18 | — | — | EP | disclosed |